Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

Coherent Market Insights
Acute Otitis Media Treatment Market, by Drug Type (Antibiotics, Nonsteroidal anti-Inflammatory drug, Analgesic, and Anaesthetic), By Formulation (Oral, and Topical), By End User (Hospitals, Retail pharmacies, and Online pharmacies) and Region - Global Trends, and Forecast to 2025

Published Date : Feb 2018

Acute Otitis Media Treatment Market - Insights Acute otitis media (AOM) is a type of ear infection in which air-filled space behind the eardrum (the middle ear) is infected and causes pain and general symptom

Coherent Market Insights
Facial Injectables Market, by Product Type (Dermal Fillers, and Anti-wrinkle Injection), by Application (Wrinkle Reduction, Facelift, Lip Enhancement, and Others) by End User (Hospitals, Dermatology Centers, Beauty Clinics, and Others), and by Region - Global Trends, and Forecast till 2025

Published Date : Feb 2018

Facial Injectables Market – Restoring the Radiance of Youth Facial injectable aid in rejuvenating facial skin by reducing or eliminating wrinkles, raising scar depressions, and enhancing lips. Facial i

Coherent Market Insights
Empty Capsules Market, by Product Type (Gelatin Capsules (Porcine, Bovine, Bone Meal), Non-Gelatin Capsules (HPMC, Pullulan)), By Application (Antibiotics, Vitamins, Anti-Inflammatory, Anti-Anemic and Others), By End User (Pharmaceutical Manufacturers, Nutraceutical Manufacturers and Others), and Region - Global Trends, and Forecast till 2025

Published Date : Feb 2018

Empty Capsules Market - Insights Capsules offer a viable alternative to tablets as an oral delivery of therapeutic compounds. Empty capsules are oral dosage forms, which based on the type of manufacturing mat

Coherent Market Insights
Multiple Sclerosis Therapeutics Market, by Drug Class (Beta Interferon, Corticosteroids, Monoclonal Antibodies, Antineoplastic Agents and Others), by Route of Administration (Oral and Injection), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and e-Commerce), and by Region - Global Trends, and Forecast till 2025

Published Date : Feb 2018

Multiple Sclerosis Therapeutics Market – Offering Long-term Disease Management Multiple sclerosis (MS) is a disabling autoimmune disease affecting the brain and the spinal cord, eventually causing nerv

Coherent Market Insights
Depression Therapeutics Market, by Drug Type (Selective Serotonin Reuptake Inhibitors (SSRIs), Selective Norepinephrine Reuptake Inhibitors (SNRIs), and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region - Global Trends, and Forecast till 2025

Published Date : Feb 2018

Depression Therapeutics Market - Insights Antidepressants are used to treat a wide range of mental disorders, including depression, anxiety, and major depressive disorder. Certain neurotransmitters in the bra

Coherent Market Insights
Hereditary Angioedema Market, by Drug Class (C1 Esterase Inhibitor, Kallikrein Inhibitor, Bradykinin Receptor, Attenuated Androgens, and Others), by Route of Administration (Subcutaneous, Intravenous, and Oral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and e-Commerce) and by Region - Global Trends and Forecast till 2025

Published Date : Feb 2018

Hereditary Angioedema Market – Efficient Disease Management for Orphan Disease Hereditary angioedema (HAE) is a rare disorder related with the immune system. The life-threatening condition is caused du

Coherent Market Insights
Prostate Cancer Therapeutics Market, by Drug Type (Hormonal Therapy, Anti-androgens, Immunotherapy, Targeted Therapy, and Chemotherapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), and by Geography - Global Trends, and Forecast to 2025

Published Date : Jan 2018

Prostate Cancer Therapeutics Market Insights Prostate cancer is caused by the uncontrolled growth of the cells in the prostate gland. Prostate cancer is the most common cancer in men in the U.S., after skin c

Coherent Market Insights
U.S. Influenza Vaccines Market, by Vaccine Type (Trivalent Vaccines and Quadrivalent Vaccines), by Virus Type (Influenza Virus Type A and Influenza Virus Type B) and by Age Group (Pediatrics and Adults) - Trends, and Forecast till 2025

Published Date : Dec 2017

U.S. Influenza Vaccines Market– Prevention of Virus through Vaccination Aids in Reducing Burden of the Disease Influenza is an infection caused by influenza virus and is commonly known as flu. Vaccinati

Coherent Market Insights
Middle East Tapentadol Market, by Therapeutic Application (Pain Management (Neuropathic Pain, Cancer Pain, and Others), and Cough Treatment), and by Countries - Trends and Forecast to 2025

Published Date : Nov 2017

Tapentadol - Become Pain Free! Tapentadol is an opioid analgesic, indicated for severe pain management, on a daily or around the clock need for treatment and long-term opioid treatment, for which alternative

Coherent Market Insights
U.S. Opioids Market, By Drugs (Codeine, Fentanyl, Meperidine, Methadone, Morphine, and Hydrocodone) and Therapeutic Application (Pain Management (Neuropathic Pain, Migraine, Back Pain, Osteoarthritis Pain, Cancer Pain, and Others), Cough Treatment, and Diarrhea Treatment) and by Geography - Trends and Forecast to 2025

Published Date : Nov 2017

Opioids Crisis – Public Health Emergency Opioids are the class of drugs that include illicit drugs such as heroin, codeine, fentanyl, meperidine, methadone, morphine, hydrocodone, diphenoxylate, hydromo

Coherent Market Insights
Global Medical Adhesives and Sealants Market, by Product Type (Synthetic and Natural), by Application (Internal, External and Dental), by End-use Industry (Hospitals, Clinics, Ambulatory Surgical Centers, Dental Clinics, and Others) and by Region - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025

Published Date : Oct 2017

Medical Adhesives and Sealants Market – Providing Adhesive Solutions Post Surgeries Medical adhesives and sealants are commonly employed in medical practices for appliance bonding and surgical procedure

Coherent Market Insights
Global Clinical Nutrition Market by Product Type (Infant Nutrition (Milk based, soy-based, Organic, Probiotics/ Prebiotics and Others), Enteral Nutrition (Standard Nutrition, Disease Specific) Parenteral Nutrition (Amino acids, Fats and Carbohydrates), and by Region - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025

Published Date : Oct 2017

Clinical Nutrition – The New Tradition is Good Nutrition Clinical nutrition products are aimed at maintaining a nutritional balance in patients, by providing sufficient amounts of nutrients, such as vit

Coherent Market Insights
Anti-epileptic Drugs for Pediatrics Market by Drug Type (1st generation, 2nd generation, and 3rd generation), and Region - Global Industry Insights, Trends, and Forecast, 2017-25

Published Date : Sep 2017

Anti-Epileptic Drugs for Pediatrics Epilepsy is associated with disrupted activities in the brain called seizures, which affects the central nervous system. Depending on the area of the brain obstructed by se

Coherent Market Insights
High Potency Active Pharmaceutical Ingredients Market, By Synthesis Route (Synthetic and Biotech), By Drug Type (Branded HPAPI and Generic HPAPI), By Manufacturer Type (In-House and Contract Research Manufacturers), and By Therapeutic Applications (Oncology, Hormonal Disorders, Glaucoma, and Others) - Global Industry Insights, Trends, Outlook and Opportunity Analysis 2017-2025

To Be Published : Mar 2018

High potency active pharmaceutical ingredients (HPAPIs) are small-molecule, biologic, or hybrids of antibody–drug conjugates, which link a cytotoxic small-molecule to a monoclonal antibody. Demand for high potency active pharmaceutical ingredients (HPAPIs) is ra

Coherent Market Insights
Large Volume Parenteral Market by Treatment Type (Fluid Balance Injections, Therapeutic Injections, and Nutritious Injections), by End User (Hospitals, Ambulatory centers, Clinics, and Others) and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017 – 2025

To Be Published : Mar 2018

Parenteral are sterile dosage form that are administered through route other than oral route of administration. They are injected into one or more layer of skin and active ingredient directly come in contact with tissue or blood vessel. Large volume parenteral are of

Coherent Market Insights
Pompe Disease Therapeutic Market, by Therapy Type (Gene Therapy, Enzyme Replacement Therapy (ERT), and Chaperone-Advanced Replacement Therapy (CHART)), by Administrational Route (Oral and Parenteral), and by Patient Type (Infants and Adults) - Global Industry Insights, Trends, Outlook and Opportunity Analysis 2017 - 2025

To Be Published : Mar 2018

Pompe disease is an inherited Lysosomal Storage Disorder (LSD) caused by a deficiency of enzyme acid named alpha-glucosidase (GAA). This causes the glycogen to accumulate in different kinds of tissues, primarily into smooth muscles, skeletal muscles and cardiac muscle

Coherent Market Insights
Stargardt Disease Therapeutics Market by Treatment Type (Drugs, Gene Therapy, and Stem Cell Therapy), By Stages of Development (Children, and Adult) By Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017 - 2025

To Be Published : Mar 2018

Stargardt disease is an inherited juvenile macular degeneration that causes vision loss. The signs and symptoms of the disease typically appear in late childhood or early adulthood, and worsen with time. The most common cause of the disease is mutations in the ABCA4 g

Coherent Market Insights
HPAPIs and Cytotoxic Drugs Manufacturing Market, By Drug Origin (Chemical-based HPAPIs and Biologic-based HPAPIs), By Manufacturing Location (In-house manufacturing and Out-sourcing), By Drug Type (Novel HPAPIs and Generic HPAPIs), By Application (Oncology and Others), and by Geography — Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : Mar 2018

High potency active pharmaceutical ingredients (HPAPIs) and cytotoxic dugs are used for creating therapeutic effect. Any active pharmaceutical ingredient (API) is considered to be potent in different scenarios. For instance, firstly when API produces biological activi

Coherent Market Insights
HDAC Inhibitors Market, by Application (Oncology, Neurology, and Others), by End User (Hospitals and Oncology Clinics), and by Geography – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2025

To Be Published : Mar 2018

HDAC inhibitors refers to the class of anti-cancer agents that play a vital role in non-epigenetic or epigenetic regulation, inducing cell cycle arrest, apoptosis, and death of cancer cells. Histone deacetylase inhibitors (HDACi) are promising therapeutics, which have

Coherent Market Insights
Viral Conjunctivitis Drugs Market, by Drug Class (Artificial tears, Decongestants, Anti-histaminic, NSAIDS, and Anti-Viral), by Distribution Channel (Hospital Pharmacy and Retail Pharmacy), and by Geography - Global Industry Insights, Trends, Outlook and Opportunity Analysis 2017-2025

To Be Published : Mar 2018

Viral conjunctivitis is an inflammation of the conjunctiva, which is a thin outermost layer of the sclera and inner layer of eyelid. Viral conjunctiva is caused due to infections from virus such as adenovirus, herpes simplex virus, varicella zoster virus, picornavirus

Coherent Market Insights
Swine Respiratory Disease Treatment Market by Treatment type (Drugs and Vaccines) by Indication (Mycoplasmal Pneumonia, Swine Influenza, Classical Swine Fever, Porcine Reproductive and Respiratory Syndrome (PRRS), Porcine Circovirus-Associated Disease, and Pseudorabies), by Distribution Channel (Veterinary Hospital and Retail Pharmacy), and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis 2017 - 2025

To Be Published : Mar 2018

Swine respiratory disease affects the respiratory tract of swine. It is one of the prevalent cause of death in nursery pigs and grower/finisher pigs. There are multiple pathogens, viruses, and other secondary causative agents that causes respiratory disease in swine.

Coherent Market Insights
Cell-Based Assay Market, By Product (Cell Lines, Microplates, Instruments, Software, Reagents and Assay Kits and Others), By Application (Drug Discovery, Predictive Toxicology, ADME Process and Others), By End-User (Pharmaceutical Companies, Biotechnology Companies, Research Organizations, Government & Academic Institutes and Others) and Geography– Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2025

To Be Published : Mar 2018

Cell-based assay refers to experiments based on living cells and is an influential tool in the research lab. Cell-based assays are vital for understanding cellular mechanism in a biological context as these assays provide information about intracellular molecular targ

Coherent Market Insights
HIV-Associated Lipodystrophy Treatment Market, by Lipodystrophy Type (Lipoatrophy and Lipoaccumulation), by Therapeutic class (Anabolism Modulators, Insulin Resistance Modulators, Mitochondrial Antioxidants (l-carnitine), and Other), by Distribution Channels (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

To Be Published : Mar 2018

HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully eluci

Coherent Market Insights
Acne Vulgaris Treatment Market, By Product Type (Medications and Devices) and by Geography – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : Mar 2018

Acne vulgaris is a common skin disease characterized by blackheads, whiteheads, papules, and pustules on the face, neck, back, and chest. It is commonly observed in adolescent population, however, can also affect adults. Depending on its severity, acne may be segmente

Coherent Market Insights
Glucagon-Like Peptide-1 (Glp-1) Analogs Market by Drug Type (Exenatide, Liraglutide, Lixisenatide, Dulaglutide, Semaglutide, and Albiglutide), by Distribution Channel (Retail pharmacy and Hospital pharmacy) and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017 – 2025

To Be Published : Mar 2018

Glucagon-like peptide-1 (GLP-1) analogs also known as incretin mimetics are class of drugs indicated for type-2 diabetes mellitus to lower the blood sugar level. GLP-1 analogs prevents the breakdown of GLP-1, thereby enhancing the glucose depended insulin release, sup

Coherent Market Insights
Crohn’s Disease Treatment Market by Drug Class (Amino salicylates, Corticosteroids, Biological agents, Immunomodulators, and Antibiotics), by Distribution channel (Retail Pharmacy and Hospital Pharmacy) and by Geography (North America, Latin America, Europe, Middle East, Asia Pacific and Africa) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017 - 2025

To Be Published : Mar 2018

Crohn’s disease is a chronic inflammatory bowel syndrome that causes inflammation in the gastrointestinal tract. Inflammation can take place anywhere between mouth to anus. It commonly affects end of small intestine (Ileum) and beginning of the colon. Common sym

Coherent Market Insights
Gaucher Disease Treatment Market, by Disease Type (Type 1 Gaucher disease, Type 2 Gaucher Disease, and Type 3 Gaucher Disease), by Therapy Type (Enzyme Replacement Therapy (ERT) and Substrate Reduction Therapy (SRT)), by Distribution Channel (Hospitals, Retail Pharmacies, and Online Pharmacies) and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

To Be Published : Mar 2018

Gaucher disease is an autosomal recessive inherited metabolism disorder where a type of fat (lipid) called glucocerebroside is unable to degrade. Body synthesis enzyme called glucocerebrosidase, which breakdowns and reprocesses glucocerebroside. Gaucher disease is cau

Coherent Market Insights
Global Bovine Respiratory Disease Treatment Market, By Disease Type (Pneumonia, Upper Respiratory Tract Infections, and Diphtheria), By Drug Type (Antibiotics, NSAIDs, Vaccines, Immunomodulators, and Others), By Distribution Channel (Veterinary Hospitals, Retail Pharmacies, and Online Pharmacies), and By Geography – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

To Be Published : Mar 2018

Bovine respiratory disease (BRD) is the most common disease, affecting the lower respiratory tract of cattle, causing bronchopneumonia and can lead to death. It is a multi-factorial syndrome that is mainly caused when a viral infection combines with a bacterial a

Coherent Market Insights
Global Major Depressive Disorder (MDD) Treatment Market, By Product Type (Drug Type (Antidepressants, Atypical antidepressants, and Antipsychotics), Neuromodulator, and Stem Cell Therapy), and by Geography- Global Industry Insights, Trends, Outlook, And Opportunity Analysis, 2025

To Be Published : Mar 2018

Major depressive disorder (MDD) also known as clinical depression is a mental health disorder which affects mood, behavior as well as appetite and sleep. The exact cause of MDD is not known, however, several factors which can increase its risk is combination of genes

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

Coherent Market Insights Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.